AstraZeneca prioritizes patient safety
2
MINS READ
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
You have these already downloaded
We have sent you a copy of the report to your email again.
Being a multinational pharma major, AstraZeneca has to comply with various standards in the regions of its operations.
It aimed to meet the regulatory and safety standards through scientific excellence and effective global processes.
The company wanted to streamline and standardize all patient safety and regulatory process workflows across its seven regional centers.
It partnered with TCS to implement a solution that integrates safety and regulatory maintenance activities.
TCS integrated processes in patient safety and regulatory services and undertook end-to-end post-approval lifecycle maintenance and surveillance activities.
This was done for more than 70 established products and over 100 products in development, in over 130 countries for AstraZeneca. TCS’ workflow solution ensured real-time tracking of products across global delivery centers and employed more than 500 experienced pharmacists and physicians to form the safety-plus-regulatory teams.
TCS’ adverse event case processing operation was inspected by the Food and Drug Administration (FDA), US, Medicines and Healthcare products Regulatory Agency (MHRA), UK, and Swedish health authorities with no critical or major findings.
The TCS’ solution enabled AstraZeneca to streamline and standardize all patient safety and regulatory process workflows across its seven regional centers.
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
EU MDR deadline extension: Making medtech manufacturers future-ready
Integrating Safety and Regulatory Functions -- A Bold Step in Pharma
Overcoming Regulatory Challenges in Personalized Medicine
TCS Clinical Operations Support Services Assuring Compliance, Quality
Integrated ecosystems are key to better patient outcomes.
Talk to our experts